Navigation Links
Cytopia Commences Phase II Cancer Drug Study
Date:12/17/2007

$3 billion by 2013.

Cytopia is also currently conducting a Phase I study investigating the safety and tolerability of CYT997 following oral administration. The company also intends to file regulatory applications in support of other Phase II studies over the coming months.

The following table provides a summary of the key aspects of the Phase II multiple myeloma trial.

Name of trial A prospective, single-arm, two-stage, open-label

Phase II trial of CYT997 in relapsed and

refractory multiple myeloma (CCL07001)

Primary endpoints Determination of the overall response rate to CYT997

Secondary endpoints Time to progression; number of cycles of CYT997 to

achieve maximum response; overall survival and

safety and tolerability

Blinding status Not blinded

Product development Drug substance and drug product are manufactured to

status GMP standards

Treatment method

Route 24 hour intravenous infusion dose

Frequency Days 1 and 8 of a 21 day cycle

Dose-levels 202 mg/m2 CYT997 dihydrochloride

Number of trial 24 patients maximum

subjects

Subject selection Eligible patients must have a diagnosis of

criteria multiple myeloma (per World Health Organisation

criteria) and have received at least one but no

more than three previous lines of therapy

Trial location Melbourne, Australia

Expected completion Interim analysis (14 patients) Q3, 2008

Trial standard ICH-GCP

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer. Cytopia conducts its research and development via subsidiaries based in
'/>"/>

SOURCE Cytopia Limited
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Exelixis Commences Public Offering of Common Stock
3. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
4. American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program
5. Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program
6. Ovation further advances development pipeline with new phase III epilepsy study
7. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
8. Mannatech Launches Phase One of New Sales and Training Tools
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Manic phase of bipolar disorder benefits from breast cancer medication
11. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Albany, New York (PRWEB) May 25, 2013 ... and substances which are used to detect and create ... available for test reading and are also known as ... of research, bioscience, diagnosis and education. , This market ... use of reagents in the field of therapeutics, growth ...
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... SATURDAY, May 25 (HealthDay News) -- Many viruses and ... rabies and leptospirosis -- a bacteria-borne illness than can ... lurking at dog parks, according to a veterinarian. ... water and even the air, said Dr. Susan Nelson, ... Health Center. "Many of these serious diseases can be ...
(Date:5/25/2013)... 2013 The report “Global Food ... Functions, Applications, Ingredients, Shell Materials, Packaging, & Geography: ... food encapsulation market with analysis and forecasting of ... identifies the driving and restraining factors for the ... opportunities, and challenges. The market is segmented and ...
(Date:5/25/2013)... Dallas, TX (PRWEB) May 25, 2013 ... between those who are carrying excessive weight and their ... that for many, simply losing weight can naturally relieve ... Medicine found that improvement in sleep quality was significantly ... this six month study dated November 6th, ...
Breaking Medicine News(10 mins):Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2
... aura about cosmetic surgery that often hovers around expecting ... Medical Defence Union insurance group// has revealed that discontentment ... reasons for seeking compensation claims. , ,It is ... has been coughed up by the MDU in the ...
... beneficial as it increases the concentration, abstract reasoning and ... say these results must be interpreted with caution//. ... University Baptist Medical Center in the US studied more ... drink a moderate amount of alcohol have slightly higher ...
... those of SMS Medical College here, called off their ... copy of the Supreme Court verdict directing medicos to ... to work, their protest would continue with the support ... strike would continue to protest the proposed 27 percent ...
... federal government plans to spend in this financial year ... activities//. Among doubts on whether this enormous expenditure is ... indicated that the expenditure is paying off and is ... study that is now available on line is due ...
... in Finland to show the increased risk of ... after watching many current T.V//. The Finnish researchers ... exposure to adult-targeted programs, such as current affairs ... They also showed that passive exposure to TV ...
... to be issued after today's UN meet on AIDS, activists ... the epidemic that has claimed 25 million lives so far.// ... UN Secretary General Kofi Annan asked diplomats not to negotiate ... ,The UNGA's session hoped to arrive at a plan that ...
Cached Medicine News:Health News:New Study Conducted To Evaluate The Success Of The Federal governments Funds For HIV/AIDS 2Health News:TV Viewing Might Increase The Risk Of Sleeping Difficulties In Children’ 2
(Date:5/24/2013)... HAYWARD, Calif. , May 24, 2013 Solta ... in the medical aesthetics market, today reported Dr. ... of the Company,s Board of Directors effective immediately.  Dr. Knowlton ... Medical and had served as a director since 1996. ... well as our management team, I would like to thank ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... 2011 VIVUS, Inc. (NASDAQ: VVUS ) today ... the European Congress on Obesity (ECO) in Istanbul, Turkey.  ECO ... the Study of Obesity (EASO). ECO is regularly attended by ... considered to be the most important annual scientific event on ...
... and Anne Wojcicki announced a $50-million challenge spurring existing and ... to The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... new or increased gifts to The Michael J. Fox Foundation ... The Brin Wojcicki Challenge will bolster MJFF,s ongoing efforts to ...
Cached Medicine Technology:Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 2Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 3Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 4Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 5Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure 2
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... provide a complete hematology profile, including a ... aggregation. Aggregation testing is based on performing ... platelet activation, using either collagen or ADP ... and no special sample preparation is required. ...
... A complete range of automatic systems for ... 1 mL of blood. With the introduction ... the clinical diagnostic market a truly revolutionary ... technical limitation associated with the traditional ESR ...
... range of automatic systems for performing erythrocyte ... of blood. With the introduction of the ... diagnostic market a truly revolutionary testing system ... associated with the traditional ESR techique.,By means ...
Medicine Products: